Table 1_A machine learning-based predictive model for 48-week hepatitis B surface antigen seroclearance in chronic hepatitis B patients treated with pegylated interferon α-2b: prediction at week 24.doc
Background<p>Chronic hepatitis B (CHB) is an infectious disease mainly affecting the liver, caused by the hepatitis B virus (HBV). In the treatment of CHB, pegylated interferon α-2b (PEG-IFNα-2b) is one of the important therapeutic options. However, there are significant individual differences...
Збережено в:
| Автор: | |
|---|---|
| Інші автори: | , , , , , , |
| Опубліковано: |
2025
|
| Предмети: | |
| Теги: |
Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|